君乐宝申请赴港上市，汇聚全球智慧深化国际合作布局

Core Insights - The dairy industry is transitioning from basic nutrition supply to precision health management, with Junlebao Dairy Group officially submitting its main board listing application to the Hong Kong Stock Exchange [1] - Junlebao aims to leverage capital market power to enhance its role as a key industry pillar in improving national health levels [1] Group 1: Research and Innovation - Research and innovation are fundamental to Junlebao's development strategy, with significant investments in R&D since launching its first infant formula in 2014 [3] - The company established a world-class R&D center in 2021, investing 500 million yuan, which integrates various disciplines and promotes a collaborative "industry-university-research" model [3] - Junlebao's R&D efforts encompass raw material selection, production process optimization, product formula development, and quality control [3] Group 2: International Collaboration - Junlebao actively seeks international cooperation to enhance its research capabilities, showcasing its strength in various fields [4] - The company achieved a significant breakthrough in functional strains research, with its core strain, Lactobacillus paracasei N1115, featured in the prestigious journal Nature in September 2025 [4] - Junlebao published a white paper on the functions and applications of human milk oligosaccharides (HMOs), marking a first in China for a comprehensive guide on HMO functionality [4] Group 3: Strategic Development - Junlebao's R&D platform, the "Scientific Nutrition Research Institute," collaborates with top research institutions and universities, covering areas such as basic research, product innovation, and clinical validation [6] - The initiation of the Hong Kong listing process signifies a new phase of integrating technology leadership with capital support, aiming to enhance core competitive advantages [6] - This strategic move is expected to inject sustained momentum into the high-quality development of China's dairy industry and open broader growth opportunities for Junlebao [6]